Navigation Links
New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
Date:5/7/2008

ion (DSM-IV-TR(R)), a publication of the American Psychiatric Association.

The CGI-I scale is a standard assessment used to rate the severity of a patient's illness and improvement over time.

The PGA is a scale that measures overall improvement as assessed by parents.

DAYTRANA(TM) is a trademark of Shire Pharmaceuticals Ireland Limited.

Important Safety Information

Tell your doctor about any heart conditions, including structural abnormalities, your child or a family member may have. Inform your doctor immediately if the child develops symptoms that suggest heart problems, such as chest pain or fainting.

DAYTRANA should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of DAYTRANA; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOI); tics, or family history or diagnosis of Tourette's syndrome.

Tell your doctor before using DAYTRANA if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness or hopelessness) or bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops any of these conditions/symptoms while using DAYTRANA.

In clinical studies, side effects were generally mild to moderate. The most common side effects reported with DAYTRANA were decreased appetite, sleeplessness, sadness/crying, twitching, weight loss, nausea, vomiting, tics and affect lability (mood swings). Aggression, new abnormal thoughts/behaviors, mania and growth suppression have been associated with use of drugs of this type. Tell your doctor if the child has blurred vision while using DAYTRANA.

Abuse of DAYTRANA can lead to dependence.


'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
2. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
3. Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
4. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
5. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
6. TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
7. TRITON-TIMI 38 Stent Analysis Favors Prasugrel
8. NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
9. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...e/ -- GlaxoSmithKline (GSK),in collaboration with...cademic breast cancer research network, and one of...erative Group (SOLTI), today announced the start,o...ole of TYKERB(R) in the,treatment of early breast ...astuzumab Treatment Optimization) will evaluate an...
(Date:5/9/2008)...tional effort probing for,answers, By Joe Kosac...ennsylvania Game Commission, NOTE: Photos to ac...he,Game Commission,s website (http://www.pgc.stat...RRISBURG, Pa., May 7 /PRNewswire-USNewswire/ -- Th... a new frontier: it is working with several,states...
(Date:5/9/2008)...-- Osteoarthritis is a,painful and potentially deb... people in the United States. It is caused by dete...nvestigational pain medication,tapentadol, a centr...elief,for patients with joint-disease pain, compar...astrointestinal side effects than those treated,wi...
(Date:5/9/2008)...llowing Bunionectomy,, TAMPA, Fla., May 9 /PRN...experience intense pain for several days following...surgeries. The investigational pain,medication tap...ho had this,surgery, compared to those treated wit... in patients reporting fewer gastrointestinal side...
Breaking Medicine Technology:TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution 13639 1Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution 13639 2Senetek PLC Announces Appointments of Key Personnel 3759 1Senetek PLC Announces Appointments of Key Personnel 3759 2Senetek PLC Announces Appointments of Key Personnel 3759 3Soaking Potatoes Before Frying Cuts Suspected Carcinogen 13637 1Soaking Potatoes Before Frying Cuts Suspected Carcinogen 13637 2New guidelines update recommendations on colorectal cancer screening 13635 1New guidelines update recommendations on colorectal cancer screening 13635 2New guidelines update recommendations on colorectal cancer screening 13635 3New guidelines update recommendations on colorectal cancer screening 13635 4
...ersonal and Social,Performance, COLORADO SPRIN...-term treatment with INVEGA(TM) (paliperidone),E...ication for,schizophrenia, helped many patients ...their improvements in personal and social,functi...n label, international,clinical trial sponsored ...
...2007 - NEOPHARM, Inc.,(Nasdaq: NEOL) today reporte...-line metastatic colorectal cancer patients with i...bolite of irinotecan,(Camptosar(R)). While the int...treatment of the first 21 patients demonstrated,di... primary tumor,response endpoint. No new patient a...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6NeoPharm Provides Update on LE-SN38 Program 2
(Date:5/12/2008)...Newswire-USNewswire/ -- Michael A.,Sandler, MD, a ...led as,president of the 15,000 member Michigan Sta...meeting of the MSMS House of Delegates on May 3 in...rsity School of Medicine, Doctor,Sandler is senior...t Henry,Ford Hospital and currently serves on the ...
(Date:5/12/2008)...RNewswire-FirstCall/ -- China Yingxia,Internationa..." or "the,Company"), a leading provider in the nut...nufacture and distribution of organic nutritional ...ucts in the People,s Republic,of China ("PRC"), an...riday, May 16, 2008, at 10:00 a.m. EDT, to discuss...
(Date:5/12/2008)...cians from Chongqing Bureau of Health, BLOOMING...thPartners,Institute for Medical Education is host...physicians ever to visit Minnesota. During their,t...tal- and clinic-based,patient care, learn about he...clinical research methodology., "We,re honored ...
(Date:5/12/2008)...ire/ -- Fairbank Farms, a national,ground beef pro...round beef,products produced at its Ashville, N.Y.... BJ,s, and Wilson Farms retail outlets and C&S Who...tain small pieces of hard plastic. All,recalled pr...5/15/08, or a,"Julian date 124" on the package,s l...
Breaking Medicine News(10 mins):Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2
...tudies have shown that salt intake is directly lin...s estimated that up to 150,000 Americans die// eac...lt. A recent study suggests salt intake and asth...eborough and Fogarty, two researchers observe that...
...h conducted by Dr. Martijn B.A. van Doorn of the C...rlands on 90 obese people revealed that garlic has...l level or allied heart ailments. The finding, wh...nal of Clinical Nutrition puts forth a theory whic...
... Lewis Rothberg of the University of Rochester was...a recent discovery by one of his team members//. ...rkable research. They developed cost effective met... This will ensure better health and clean drinking...
...: A 14 year old teenage boy is confirmed to be sev... and is presently undergoing treatment//, an Indon...first human case of bird flu in 2007; with this, t...n the region is 75, out of which 57 did not surviv...
Other Medicine News:Health News:Quick and Inexpensive DNA Testing 2
The Self-Cath Closed System is a latex-free unisex system that provides a method for safe, simple catheterization designed to reduce the risk of urinary tract infections. It includes a 100% latex-fr
The Self-Cath family of 100% latex-free catheters offers patients a variety of options for intermittent self-catheterization. Each catheter is made of flexible medical grade PVC and has smooth fire
The Self-Cath family of 100% latex-free catheters offers patients a variety of options for intermittent self-catheterization. Each catheter is made of flexible medical grade PVC and has smooth fire
An indirect immunofluorescence antibody test for the detection and semi-quantitation of anti-neutrophil cytoplasmic antibodies (ANCA) in human serum. ANCA are found in the sera of patients with necro
Medicine Products: